FOTODINAMIK TERAPIYA YORDAMIDA BLEFARITLARNI KOMPLEKS DAVOLASHNI KLINIK-LABORATOR BAHOLASH

Relevance. Blepharitis is a common inflammatory eyelid disease, particularly in its chronic form, which is resistant to therapy. Purpose of the study. To optimize the comprehensive treatment of blepharitis using photodynamic therapy (PDT). Materials and methods. The study involved 60 patients divided into control and main groups. The control group received standard therapy, including a 0.02% furacilin solution, warm compresses, and 1% tetracycline ointment. The main group, in addition to standard treatment, underwent photodynamic therapy. Results. The combined use of photodynamic therapy accelerated inflammation resolution—by day 3, the index decreased 2.84 times, and by day 7, inflammation was absent in all patients. Eyelid swelling and hyperemia resolved by days 3–5 (compared to 7 days in the control group). Pathogenic microflora was absent in 83.5% of patients by days 4–5 (compared to 7–8 days in the control group). Conclusions. Photodynamic therapy effectively eliminates inflammation, improves the clinical picture in 83.5% of patients, and reduces treatment duration to 5–6 days.

Ҳали таржима қилинмаган